The janus kinase inhibitor, JAB/SOCS-1, is an interferon-γ inducible gene and determines the sensitivity to interferons

Leukemia and Lymphoma

Volumn 38, Issue 1-2, 2000, Pages 49-58

  Sakamoto, Hiroshi ^a   Kinjyo, Ichiko ^a   Yoshimura, Akihiko ^a  

^a KURUME UNIVERSITY   (Japan)

Author keywords

CIS; Interferon ; JAB; JAK; Negative regulation; SH2 domain; SOCS; SSI; STAT; Tyrosine kinase

Indexed keywords

GAMMA INTERFERON; JANUS KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

DRUG SENSITIVITY; ENZYME INHIBITION; GENE INDUCTION; KNOCKOUT MOUSE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0034050676     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009060318     Document Type: Review

References (47)

1. Darnell, J.E. Jr. (1997) STATs and Gene Regulation. Science, 277, 1630-1635.
2. Hoey, T., Schindler, U. (1998) STAT structure and function in signaling. Curr. Opin. Genet. Dev., 8, 582-587.
3. Liu, K.D., Gaffen, S.L., Goldsmith, M.A. (1998) JAK/STAT signaling by cytokine receptors. Curr. Opin. Immunol., 10, 271-278.
4. Leonard, W.J., O'Shea, J.J. (1998) Jaks and STATs: biological implications. Annu. Rev. Immunol., 16, 293-322.
5. Kim, T.K., Maniatis, T. (1996) Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science, 273, 1717-1719.
6. Strous, G.J., van Kerkhof, P., Govers, R., Ciechanover. A., Schwartz, A.L. (1996) The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor. EMBO J, 15, 3806-3812.
7. Callus, B.A., Mathey-Prevot, B. (1998) Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors. Blood, 91, 3182-3192.
8. Wang, D., Stravopodis, D., Teglund, S., Kitazawa, J., Ihle, J.N. (1996) Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol., 16, 6141-6148.
9. Azam, M., Lee, C., Strehlow, I., Schindler, C. (1997) Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity, 6, 691-701.
10. Chung, C.D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., Shuai, K. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science, 278, 1803-1805.
11. Liu, B., Liao, J., Rao, X., Kushner, S.A., Chung, C.D., Chang, D.D., Shuai, K. (1998) Inhibition of Stat 1-mediated gene activation by PIASI. Proc. Natl. Acad. Sci. USA, 95, 10626-10631.
12. Migone, T.S., Cacalano, N.A., Taylor, N., Yi, T., Waldmann, T.A., Johnston, J.A. (1948) Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. Proc. Natl. Acad. Sci. USA. 95, 3845-3850.
13. David, M., Chen, H.E., Goetz, S., Larner, A.C., Neel, B.G. (1995) Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTPI. Mol. Cell. Biol., 15, 7050-7058.
14. Shu cell protein-tyrosine phosphatase (Hcph) gene. Cell, 73, 1445-1454.
15. You, M., Yu, D.H., Feng, G.S. (1999) Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol. Cell. Biol., 19, 2416-2424.
16. Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D.J., Penninger, J.M. (1999) SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev., 13, 786-791.
17. Ueno, H., Sasaki, K., Miyagawa, K., Honda, H., Mitani, K., Yazaki, Y., Hirai, H. (1997) Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor receptor signaling. J. Biol. Chem., 272, 8739-8743.
18. Yoshimura, A. (1998) The CIS/JAB family: novel negative regulators of JAK signaling pathways. Leukemia, 12, 1851-1857.
19. Yoshimura, A. (1998) The CIS family: negative regulators of JAK-STAT signaling. Cytokine Growth Factor Rev. 9. 197-204.
20. Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N.A., Gilbert, D.J., Copeland, N.G., Hara, T., Miyajima, A. (1995) A novel cytokine-inducible gene CIS encodes an SH2 containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J., 14, 2816-2826.
21. Uchida, K., Yoshimura, A., Inazawa, J., Yanagisawa, K., Osada, H., Masuda, A., Saito, T., Takahashi, T., Miyajima, A., Takahashi, T. (1997) Molecular cloning of CISH, chromosome assignment to 3p21.3, and analysis of expression in fetal and adult tissues. Cytogenet. Cell. Genet., 78, 209-212.
22. Matsumoto, A., Masuhara, M., Mitsui, K., Yokouchi, M., Ohtsubo, M., Misawa, H., Miyajima, A., Yoshimura, A. (1997) CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STATS activation. Blood, 89, 3148-3154.
23. Verdier, F., Chretien, S., Muller, O., Varlet, P., Yoshimura, A., Gisselbrecht, S., Lacombe, C., Mayeux, P. (1998) Proteasomes Regulate Erythropoietin Receptor and Signal Transducer and Activator of Transcription 5 (STAT5) Activation. POSSIBLE INVOLVEMENT OF THE UBIQUITINATED CIS PROTEIN. J. Biol. Chem., 273, 28185-28190.
24. Matsumoto, A., Seki, Y., Kubo, M., Ohtsuka, S., Suzuki, A., Hayashi, I., Tsuji, K., Nakahata, T., Okabe, M., Yamada, S., and Yoshimura, A. (1999) Suppression of STAT5 Functions in Liver, Mammary Glands, and T Cells in Cytokine-Inducible SH2-Containing Protein I Transgenic Mice. Mol. Cell Biol., 19, 6396-6407.
25. Udy, G.B., Towers, R.P., Snell, R.G., Wilkins, R.J., Park, S.H., Ram, P.A., Waxman, D.J., Davey, H.W. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA, 94, 7239-7244.
26. Liu, X., Robinson, G.W., Wagner, K.U., Garrett, L., Wynshaw-Boris, A., Hennighausen, L. (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev., 11, 179-186.
27. Nakajima, H., Liu, X.W., Wynshaw-Boris, A., Rosenthal, L.A., Imada, K., Finbloom, D.S., Hennighausen, L., Leonard, W.J. (1997) An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity, 7, 691-701.
28. Teglund, S., McKay, C., Schuetz, E., van Deursen, J.M., Stravopodis, D., Wang, D., Brown, M., Bodner, S., Grosveld, G., Ihle, J.N. (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell, 93, 841-850.
29. Moriggl, R., Topham, D.J., Teglund, S., Sexl, V., McKay, C., Wang, D., Hoffmeyer, A., van Deursen, J., Sangster, M.Y., Bunting, K.D., Grosveld, G.C., Ihle, J.N. (1999) Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity, 10, 249-259.
30. Starr, R., Willson, T.A., Viney, E.M., Murray, L.J., Rayner, J.R., Jenkins, B.J., Gonda, T.J. Alexander, W.S., Metcalf, D., Nicola, N.A., Hilton, D.J. (1997) A family of cytokine-inducible inhibitors of signalling. Nature, 387, 917-921.
31. Endo, T.A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., Miyazaki, T., Leonor, N., Taniguchi, T., Fujita, T., Kanakura, Y., Komiya, S., Yoshimura, A. (1997) A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 387, 921-924.
32. Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., Akira, S., Kishimoto, T. (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature, 387, 924-929.
33. Masuhara, M., Sakamoto, H., Matsumoto, A., Suzuki, R., Yasukawa, H., Mitsui, K., Wakioka, T., Tanimura, S., Sasaki, A., Misawa, H., Yokouchi, M., Ohtsubo, M., Yoshimura, A. (1997) Cloning and Characterization of Novel CIS Family Genes. Biochem. Biophys. Res. Commun., 239, 439-446.
34. Hilton, D.J., Richardson, R.T., Alexander, W.S., Viney, E.M., Willson, T.A., Sprigg, N.S., Starr, R., Nicholson, S.E., Metcalf, D., Nicola, N.A. (1998) Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA, 95, 114-119.
35. Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin, W.G. Jr., Conaway, R.C., Conaway, J.W. (1998) The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev., 12, 3872-3881.
36. Zhang, J.G., Farley, A., Nicholson, S.E., Willson, T.A., Zugaro, L.M., Simpson, R.J., Moritz, R.L., Cary, D., Richardson, R., Hausmann, G., Kile, B.J., Kent, S.B., Alexander, W.S., Metcalf, D., Hilton, D.J., Nicola, N.A., Baca, M. (1999) The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA, 96, 2071-2076.
37. Suzuki, R., Sakamoto, H., Yasukawa, H., Masuhara, M., Wakioka, T., Sasaki, A., Yuge, K., Komiya, S., Inoue, A., Yoshimura, A. (1998) CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells. Oncogene, 17, 2271-2278.
38. Sakamoto, H., Yasukawa, H., Masuhara, M., Tanimura, S., Sasaki, A., Yuge, K., Ohtsubo, M., Ohtsuka, S., Fujita, T., Ohta, T., Furukawa, Y., Iwase, S., Yamada, H., Yoshimura, A. (1998) A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood, 92, 1668-1676.
39. Naka, T., Matsumoto, T., Narazaki, M., Fujimoto, M., Morita, Y., Ohsawa, Y., Saito, H., Nagasawa, T., Uchiyama, Y., Kishimoto, T. (1998) Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA, 95, 15577-15582.
40. Starr, R., Metcalf, D., Elefanty, A.G., Brysha, M., Willson, T.A., Nicola, N.A., Hilton, D.J., Alexander, W.S. (1998) Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA, 95, 14395-14399.
41. Alexander, W.S., Starr, R., Fenner, J.E., Scott, C.L., Handman, E., Sprigg, N.S., Corbin, J.E., Cornish, A.L., Darwiche, R., Owczarek, C.M., Kay, T.W.H., Nicola, N.A., Hertzog, P.J., Metcalf, D., Hilton, D.J. (1999) SOCSI Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine. Cell, 98, 597-608.
42. Marine, J.-C., Topham, D.J., McKay, C., Wang, D., Parganas, E., Stravopodis, D., Yoshimura, A., Ihle, J.N. (1999) SOCSI Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality. Cell, 98, 609-616.
43. Metcalf, D., Alexander, W.S., Elefanty, A.G., Nicola, N.A., Hilton, D.J., Starr, R., Mifsud, S., Di Rago, L. (1999) Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-I. Leukemia, 13, 926-934.
44. Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J.N., Yoshimura, A. (1999) The JAK-Binding Protein JAB Inhibits Janus Tyrosine Kinase Activity Through Binding in the Activation Loop. EMBO J., 18, 1309-1320.
45. Nicholson, S.E., Willson, T.A., Farley, A., Starr, R., Zhang, J.G., Baca, M., Alexander, W.S., Metcalf, D., Hilton, D.J., Nicola, N.A. (1999) Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J., 18, 375-385.
46. Sasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., Kinjyo, I., Sasaki, M., Johnston, J.A., Yoshimura, A. (1999) Cytokine-inducible SH2 protein-3 (CIS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes to Cells, 4, 339-351.
47. Marine, J.-C., McKay, C., Wang, D., Topham, D.J., Parganas, E., Nakajima, H., Pendeville, H., Yasukawa, H., Sasaki, A., Yoshimura, A., Ihle, J.N. (1999) SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis. Cell, 98, 617-627.